FindTrial
Sign In

KTP Green Light Prostatectomy Compared With TUR-P in High Risk Patients

The Effect of KTP (Potassium-titanyl-phosphate) Green Light Prostatectomy (120W) Compared With TUR-P When Treating Benign Prostatic Hyperplasia in High Risk Patients, A Prospective Randomized Study

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02075736
Enrollment
40
Registered
2014-03-03
Start date
2011-03-31
Completion date
2025-12-31
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BPH (Benign Prostatic Hyperplasia)

Brief summary

The purpose of this study is to compare safety and efficacy of Green Light PVP (Photoselective Vaporization of the Prostate) compared to TUR-P in high risk patients

Interventions

PROCEDUREKTP laser
PROCEDURETUR-P

device

Sponsors

University of Helsinki
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
40 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Men with anticoagulant medication undergoing surgery for BPH

Exclusion criteria

* Previous prostate surgery * Carcinoma of the prostate * Neurogenic bladder * Bladder carcinoma

Design outcomes

Primary

MeasureTime frame
Re-bleeding rate requiring hospitalizationtwo months postoperatively

Secondary

MeasureTime frameDescription
Length of catheterizationParticipants will be followed for the duration of hospital stay, an expected maximum of one week—
IPSS (International Prostate Symptom Score)0, 3, 6 and 12 monthssymptom score
DAN-PSS (Danish Prostate Symptom Score)0, 3, 6 and 12 months—
Maximum flow rate (Qmax)0, 3, 6 and 12 months—
Residual urine0, 3, 6 and 12 months—
Perioperative bleedingTime of operation—
IIEF (International Index of Erectile Function) questionnaire0,12 months—
TRUS (transrectal ultrasound)0, 12 months—
Length of hospital stayParticipants will be followed for the duration of hospital stay, an expected maximum of one week—

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026